Results 81 to 90 of about 731,563 (181)

不同种类活性炭对mZVI/活性炭吸附还原Cr(Ⅵ)的影响

open access: yesGongye shui chuli
基于活性炭(AC)的良好吸附性能和其可与微米零价铁(mZVI)结合形成微电解体系的特性,采用球磨法(BM)合成多种mZVI/ACs复合材料,并探讨该类材料对Cr(Ⅵ)的去除效能,对最佳复合材料去除Cr(Ⅵ)的机理进行解析。研究结果表明,BM可使AC与mZVI有效结合,短时球磨条件下mZVI/AC(木质)对Cr(Ⅵ)的去除效果较优。溶液中的Cr(Ⅵ)主要由次生Fe2+还原,而AC不仅可加强mZVI/AC对Cr(Ⅵ)的吸附,而且还促进了mZVI的腐蚀,进而强化了对Cr(Ⅵ)的去除。通过监测Cr(Ⅵ ...
王文豪   +5 more
doaj   +2 more sources

Anticoagulation Treatment Response Among Phenotypic ESUS Clusters: Evidence From CASPR

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective To evaluate treatment effect heterogeneity across phenotypic clusters of patients with cryptogenic embolic stroke using causal inference methods. Methods From a retrospective, multicenter cohort of patients with cryptogenic embolic stroke, we estimated the treatment effect of anticoagulation versus antiplatelet therapy in patients ...
Elena Badillo Goicoechea   +53 more
wiley   +1 more source

响应面法优化粉末活性炭去除水中的Cr(Ⅵ)

open access: yesGongye shui chuli, 2017
研究了粉末活性炭(PAC)吸附去除水溶液中的Cr(Ⅵ),利用基于单因素实验的响应面法优化了Cr(Ⅵ)的去除条件。结果表明,模型能很好地拟合实验数据。当Cr(Ⅵ)初始质量浓度为50 mg/L时,由响应面法得到的Cr(Ⅵ)最佳去除条件是:pH=3、吸附时间为21.56 min、PAC投加质量浓度为2.40 g/L,相应的Cr(Ⅵ)的去除率为86.00%。实验值和预测值的相对偏差仅为1.07%,证实模型合理可行。
王文强, 王爱丽
doaj   +2 more sources

Clinical Variability and Genotype Driven Outcomes in an International Cohort of 14 Pediatric FIG4 Patients

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Background Biallelic FIG4 variants classically cause distinct conditions characterized by peripheral neuropathy (Charcot‐Marie‐Tooth disease type 4J) or skeletal dysplasia (Yunis‐Varón syndrome). However, central nervous system involvement is increasingly recognized. The prevalence and specific characteristics of movement disorders within FIG4‐
Andrea Gangfuß   +22 more
wiley   +1 more source

Study on Treatment of Cr (VI)-Containing Wastewater with Nitric Acid Modified Activated Carbon

open access: yes, 2011
After activated carbon is oxidized and modified with nitric acid (1:1), its cation exchange capacity can amount to 1.840 mmol • g-1. The modified activated carbon is used as adsorbent for the treatment of Cr (Ⅵ)-containing wastewater at room temperature,
Xiu Ling Song, Hui Qian
core   +1 more source

水热改性花生壳对水中Cr(Ⅵ)的吸附性能

open access: yesGongye shui chuli, 2017
为解决水体Cr(Ⅵ)污染,实现农业固废资源化利用,通过水热H3PO4改性制备了花生壳基吸附剂,并将其用于水中Cr(Ⅵ)的吸附。实验结果表明,在453 K下,与质量分数为15%的H3PO4水热反应10 h制备的改性花生壳性能最优;当吸附剂投加量为2 g/L,pH=2.0,Cr(Ⅵ)初始质量浓度为5 mg/L,吸附时间为120 min时,水中Cr(Ⅵ)去除率可达86.83%。改性花生壳对Cr(Ⅵ)的吸附过程符合伪二级动力学模型,属于Langmuir单分子层吸附。
孟祥霞, 邬欣慧, 马东, 吴娟
doaj   +2 more sources

Axial Function Reflects Global Severity in Inherited Ataxias: The Upright Stability Score in Ambulatory Friedreich vs. Spinocerebellar Ataxia

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Inherited ataxias are clinically diverse neurodegenerative diseases, complicating the choice of outcome measures for trials. In spinocerebellar ataxia (SCA), regulatory concerns about the Scale for the Assessment and Rating of Ataxia (SARA) caused a shift toward functional SARA (f‐SARA), contributing to pivotal trial failure.
Christian Rummey   +52 more
wiley   +1 more source

Photocatalytic Degradation of Cr (Ⅵ) and 2-Naphthol in Water Using Sulfur-doped TiO2 Catalyst

open access: yes, 2015
采用自制的S/Ti O2作为光催化剂,在可见光下进行光催化降解2-萘酚和还原Cr(VI)的实验。考察了S/Ti O2投加量、2-萘酚初始浓度和p H值对2-萘酚降解光催化性能的影响及Cr(VI)~2-萘酚混合体系光催化反应的研究。结果表明:S/Ti O2投加量为2.0 g/L,2-萘酚溶液初始浓度18.75 mg/L,p H值为6~7时2-萘酚光催化降解效果最好;混合体系中的2-萘酚的降解率及Cr(VI)还原率均较相应的单一体系高,Cr(VI)的还原与2-萘酚的氧化之间产生了协同效应。Cr(VI)和2 ...
张博涵, 李国磊, 夏璐, 邓啟敏
core  

From Adult to Adolescent: Alignment in Clinical Trials and Outcomes in Axial Spondyloarthritis

open access: yesArthritis Care &Research, EarlyView.
Spondyloarthritis (SpA) is a group of chronic inflammatory diseases encompassing axial and peripheral forms, with up to 20% of patients developing symptoms before age 16. Despite this substantial pediatric burden, treatment options for juvenile‐onset SpA (JSpA), particularly those with axial disease (axJSpA), remain limited.
Pamela F. Weiss   +9 more
wiley   +1 more source

Short‐Term Response to Biologic Therapy in Psoriatic Arthritis Is Not Influenced by Disease Duration at Initiation of Therapy

open access: yesArthritis Care &Research, EarlyView.
Objective We aimed to determine whether the short‐term response to biologics in biologic‐naive psoriatic arthritis (PsA) is better in patients initiating biologic treatment early in the disease course. Methods Patients with PsA who started on biologic therapy from the year 2000 to 2025 were included for analysis.
Sung Min Cho   +4 more
wiley   +1 more source

Home - About - Disclaimer - Privacy